EP3097212A4 - Méthodes et compositions pour des séquences guidant le ciblage de cas9 - Google Patents

Méthodes et compositions pour des séquences guidant le ciblage de cas9 Download PDF

Info

Publication number
EP3097212A4
EP3097212A4 EP15740979.8A EP15740979A EP3097212A4 EP 3097212 A4 EP3097212 A4 EP 3097212A4 EP 15740979 A EP15740979 A EP 15740979A EP 3097212 A4 EP3097212 A4 EP 3097212A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
cas9 targeting
sequences
guiding cas9
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP15740979.8A
Other languages
German (de)
English (en)
Other versions
EP3097212A2 (fr
Inventor
Rodolphe Barrangou
Kurt M. SELLE
Alexandra E. BRINER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North Carolina State University
University of California
Original Assignee
North Carolina State University
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Carolina State University, University of California filed Critical North Carolina State University
Publication of EP3097212A2 publication Critical patent/EP3097212A2/fr
Publication of EP3097212A4 publication Critical patent/EP3097212A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
EP15740979.8A 2014-01-24 2015-01-23 Méthodes et compositions pour des séquences guidant le ciblage de cas9 Pending EP3097212A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461931515P 2014-01-24 2014-01-24
PCT/US2015/012747 WO2015112896A2 (fr) 2014-01-24 2015-01-23 Méthodes et compositions pour des séquences guidant le ciblage de cas9

Publications (2)

Publication Number Publication Date
EP3097212A2 EP3097212A2 (fr) 2016-11-30
EP3097212A4 true EP3097212A4 (fr) 2017-10-04

Family

ID=53682132

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15740979.8A Pending EP3097212A4 (fr) 2014-01-24 2015-01-23 Méthodes et compositions pour des séquences guidant le ciblage de cas9

Country Status (4)

Country Link
EP (1) EP3097212A4 (fr)
JP (4) JP2017503514A (fr)
CA (1) CA2936646A1 (fr)
WO (1) WO2015112896A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110117622A (zh) * 2019-05-24 2019-08-13 青岛农业大学 一种CRISPR/Cas基因编辑系统及其制备方法和应用

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6261500B2 (ja) 2011-07-22 2018-01-17 プレジデント アンド フェローズ オブ ハーバード カレッジ ヌクレアーゼ切断特異性の評価および改善
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
LT3036327T (lt) 2013-08-22 2019-06-25 Pioneer Hi-Bred International, Inc. Genomo modifikacijos, panaudojant nukreipiančias polinukleotido/cas endonukleazės sistemas, ir panaudojimo būdai
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9340800B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College Extended DNA-sensing GRNAS
US10584358B2 (en) 2013-10-30 2020-03-10 North Carolina State University Compositions and methods related to a type-II CRISPR-Cas system in Lactobacillus buchneri
AU2014346559B2 (en) 2013-11-07 2020-07-09 Editas Medicine,Inc. CRISPR-related methods and compositions with governing gRNAs
US11053481B2 (en) 2013-12-12 2021-07-06 President And Fellows Of Harvard College Fusions of Cas9 domains and nucleic acid-editing domains
WO2015112896A2 (fr) * 2014-01-24 2015-07-30 North Carolina State University Méthodes et compositions pour des séquences guidant le ciblage de cas9
JP2017512481A (ja) 2014-04-08 2017-05-25 ノースカロライナ ステート ユニバーシティーＮｏｒｔｈ Ｃａｒｏｌｉｎａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ Ｃｒｉｓｐｒ関連遺伝子を用いた、ｒｎａ依存性の転写抑制のための方法および組成物
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
EP3633032A3 (fr) 2014-08-28 2020-07-29 North Carolina State University Nouvelles protéines cas9 et éléments de guidage pour le ciblage de l'adn et l'édition du génome
CN107567499A (zh) 2015-03-27 2018-01-09 纳幕尔杜邦公司 大豆u6核小rna基因启动子及其在植物小rna基因的组成型表达中的用途
AU2016265560B2 (en) * 2015-05-15 2022-07-28 Pioneer Hi-Bred International, Inc. Rapid characterization of Cas endonuclease systems, PAM sequences and guide RNA elements
US10136649B2 (en) 2015-05-29 2018-11-27 North Carolina State University Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids
FI3307872T3 (fi) 2015-06-15 2023-10-16 Univ North Carolina State Menetelmiä ja koostumuksia nukleiinihappojen ja rna-pohjaisten antimikrobien tehokkaaseen antamiseen
US9580727B1 (en) 2015-08-07 2017-02-28 Caribou Biosciences, Inc. Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
WO2017058751A1 (fr) 2015-09-28 2017-04-06 North Carolina State University Méthodes et compositions pour agents antimicrobiens spécifiques d'une séquence
WO2017070632A2 (fr) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Éditeurs de nucléobases et leurs utilisations
US11542466B2 (en) 2015-12-22 2023-01-03 North Carolina State University Methods and compositions for delivery of CRISPR based antimicrobials
CN105594664B (zh) * 2016-02-16 2018-10-02 湖南师范大学 一种基因敲除选育stat1a基因缺失型斑马鱼的方法
WO2018027078A1 (fr) 2016-08-03 2018-02-08 President And Fellows Of Harard College Éditeurs de nucléobases d'adénosine et utilisations associées
CA3033327A1 (fr) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Proteines de fusion cas9-recombinase programmables et utilisations associees
WO2018039438A1 (fr) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation d'acides aminés non naturels dans des protéines au moyen de l'édition de bases
GB2573062A (en) 2016-10-14 2019-10-23 Harvard College AAV delivery of nucleobase editors
WO2018119359A1 (fr) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Édition du gène récepteur ccr5 pour protéger contre l'infection par le vih
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
WO2018165629A1 (fr) 2017-03-10 2018-09-13 President And Fellows Of Harvard College Éditeur de base cytosine à guanine
KR20190130613A (ko) 2017-03-23 2019-11-22 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
WO2018217981A1 (fr) 2017-05-26 2018-11-29 North Carolina State University Arn guides modifiés pour moduler l'activité cas9 et procédés d'utilisation
US11866726B2 (en) 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
WO2019139645A2 (fr) 2017-08-30 2019-07-18 President And Fellows Of Harvard College Éditeurs de bases à haut rendement comprenant une gam
WO2019079347A1 (fr) 2017-10-16 2019-04-25 The Broad Institute, Inc. Utilisations d'éditeurs de bases adénosine
EP3755792A4 (fr) * 2018-02-23 2021-12-08 Pioneer Hi-Bred International, Inc. Nouveaux orthologues de cas9
US10711267B2 (en) 2018-10-01 2020-07-14 North Carolina State University Recombinant type I CRISPR-Cas system
BR112021011372A2 (pt) 2018-12-14 2021-08-31 Pioneer Hi-Bred International, Inc. Novos sistemas crispr-cas para edição de genoma
KR20210143230A (ko) 2019-03-19 2021-11-26 더 브로드 인스티튜트, 인코퍼레이티드 뉴클레오티드 서열을 편집하기 위한 방법 및 조성물
WO2020263773A1 (fr) * 2019-06-24 2020-12-30 North Carolina State University Procédés et compositions pour modifier des génomes bactériens et pour tuer des bactéries
US20230332218A1 (en) * 2020-04-21 2023-10-19 Mammoth Biosciences, Inc. Casy programmable nucleases and rna component systems
CN116096873A (zh) 2020-05-08 2023-05-09 布罗德研究所股份有限公司 同时编辑靶标双链核苷酸序列的两条链的方法和组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013176772A1 (fr) * 2012-05-25 2013-11-28 The Regents Of The University Of California Procédés et compositions permettant la modification de l'adn cible dirigée par l'arn et la modulation de la transcription dirigée par l'arn

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015112896A2 (fr) * 2014-01-24 2015-07-30 North Carolina State University Méthodes et compositions pour des séquences guidant le ciblage de cas9

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013176772A1 (fr) * 2012-05-25 2013-11-28 The Regents Of The University Of California Procédés et compositions permettant la modification de l'adn cible dirigée par l'arn et la modulation de la transcription dirigée par l'arn

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110117622A (zh) * 2019-05-24 2019-08-13 青岛农业大学 一种CRISPR/Cas基因编辑系统及其制备方法和应用

Also Published As

Publication number Publication date
JP2024041934A (ja) 2024-03-27
JP7429057B2 (ja) 2024-02-07
EP3097212A2 (fr) 2016-11-30
CA2936646A1 (fr) 2015-07-30
WO2015112896A2 (fr) 2015-07-30
JP2017503514A (ja) 2017-02-02
JP2022106883A (ja) 2022-07-20
WO2015112896A9 (fr) 2015-11-26
JP2020103295A (ja) 2020-07-09
WO2015112896A3 (fr) 2015-10-29

Similar Documents

Publication Publication Date Title
EP3097212A4 (fr) Méthodes et compositions pour des séquences guidant le ciblage de cas9
EP3355954A4 (fr) Méthodes et compositions d'administration
EP3328377A4 (fr) Compositions et méthodes pour thérapies immuno-oncologiques
EP3151846A4 (fr) Méthodes et compositions de conception de nucléase
EP3190894A4 (fr) Compositions microbiennes et procédés associés
EP3110945A4 (fr) Compositions et procédés de modification génomique dirigée
EP3288387A4 (fr) Compositions microbiennes et procédés de bioprotection
EP3152222A4 (fr) Compositions et procédés pour cibler une voie
EP3200802A4 (fr) Compositions et méthodes pour améliorer la fonction cognitive
EP3229849A4 (fr) Compositions d'additifs pour la désinfection pigmentée et procédés correspondants
EP3307296A4 (fr) Procédés et compositions pour traiter des états associés au vieillissement
EP3200815A4 (fr) Procédés et compositions pour le traitement du cancer
IL246879B (en) Preparations of Epilimod and methods of using them
EP3139928A4 (fr) Compositions d'anordrine et méthodes de traitement de maladies
EP3442543A4 (fr) Compositions et méthodes pour la neurogenèse
EP3394272A4 (fr) Compositions et procédés permettant de cibler efficacement des transgènes
EP3347025A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3110446A4 (fr) Procédés et compositions pour le traitement de maladies associées à siglec-8
EP3253389A4 (fr) Compositions d'apilimod et procédés d'utilisation correspondants
EP3324932A4 (fr) Compositions et procédés pour formes de substance lyophile de nanoparticules
EP3198275A4 (fr) Compositions sterilization et méthodes
EP3148564A4 (fr) Procédés et compositions pour une immunomodulation
EP3002312B8 (fr) Compositions durcissables
EP3154544A4 (fr) Compositions et procédés de traitement de cancers
EP3164132A4 (fr) Méthodes et compositions pour le traitement de maladies et d'affections

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160824

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SELLE, KURT M.

Inventor name: BARRANGOU, RODOLPHE

Inventor name: BRINER, ALEXANDRA E.

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170831

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/85 20060101ALI20170825BHEP

Ipc: C12N 15/113 20100101ALI20170825BHEP

Ipc: C12N 15/00 20060101ALI20170825BHEP

Ipc: C07H 21/04 20060101ALI20170825BHEP

Ipc: A61K 48/00 20060101ALI20170825BHEP

Ipc: C12P 19/34 20060101ALI20170825BHEP

Ipc: C12Q 1/68 20060101AFI20170825BHEP

Ipc: C12N 9/16 20060101ALI20170825BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20181030

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS